Evidence map›Paper›PMID 26940867›Full record

ArticleScience (New York, N.Y.)2016

Activation of proto-oncogenes by disruption of chromosome neighborhoods.

Denes Hnisz, Abraham S Weintraub, Daniel S Day, Anne-Laure Valton, Rasmus O Bak, Charles H Li, Johanna Goldmann, Bryan R Lajoie, Zi Peng Fan, Alla A Sigova and 7 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 655 papers.

0numbers the graph read from it
0cells of the map it votes in
655citing papers in PubMed
73.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

655 citing papers in PubMed, 1,099 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Evolution of CTCF binding sites in the human genome.Molecular biology and evolution · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. SMARCD1 and Its Functional Relevance in SWI/SNF and Cancer.International journal of molecular sciences · 2026
    Review
  14. Article
  15. Disruption of CTCF binding by germline non-coding variants inmedRxiv : the preprint server for health sciences · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

595 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Denes Hnisz *Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Abraham S Weintraub *Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Daniel S DayWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Anne-Laure ValtonProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605-0103, USA.
Rasmus O BakDepartment of Pediatrics, Stanford University, Stanford, California, USA.
Charles H LiWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Johanna GoldmannWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Bryan R LajoieProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605-0103, USA.
Zi Peng FanWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Alla A SigovaWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Jessica ReddyWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Diego Borges-RiveraWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Tong Ihn LeeWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Rudolf JaenischWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Matthew H PorteusDepartment of Pediatrics, Stanford University, Stanford, California, USA.
Job DekkerProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605-0103, USA.
Richard A YoungWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Whitehead Institute for Biomedical Research · USMassachusetts Institute of Technology · USUniversity of Massachusetts Chan Medical School · USStanford University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
The Molecular Function of D-cyclins in T-ALLP01CA109901 · NCI · DANA-FARBER CANCER INSTITUTE · PI YOUNG, RICHARD · 2004 to 2014
$19.6M
Transcriptional Regulatory Networks in Living CellsR01HG002668 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI YOUNG, RICHARD · 2003 to 2016
$17.9M
Structural Annotation of the Human GenomeR01HG003143 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Job Dekker · 2003 to 2026
$15.4M
Center for 3D Structure and Physics of the GenomeU54DK107980 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DEKKER, JOB · 2015 to 2019
$14.9M
A Comprehensive Catalog of Dnasel Hypersensitive SitesU54HG007010 · NHGRI · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, JOHN A · 2012 to 2016
$12.4M
Spatio-Temporal Organization of Chromatin and Information Transfer in CancerU54CA193419 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI O'HALLORAN, THOMAS V · 2015 to 2020
$10.4M
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like CellsR37HD045022 · NICHD · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF · 2009 to 2017
$7.5M
Transcriptional condensates, epigenetic editing and Rett SyndromeR01MH104610 · NIMH · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, YOUNG, RICHARD · 2014 to 2023
$7.4M
Rules of gene expression modeled on human dendritic cell response to pathogensU01HG007910 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARBER, MANUEL, LUBAN, JEREMY · 2015 to 2017
$6.1M
An iPSC based platform for functionally assessing genetic and environmental riskR01NS088538 · NINDS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, MYERS, RICHARD H · 2014 to 2018
$5.0M
Howard Hughes Medical InstituteNCI NIH HHS CA109901NCI NIH HHS P01 CA109901NCI NIH HHS P30 CA014051NCI NIH HHS U54 CA193419NHGRI NIH HHS HG002668NHGRI NIH HHS R01 HG002668NHGRI NIH HHS R01 HG003143NHGRI NIH HHS R25 HG007631NHGRI NIH HHS U01 HG007910NHGRI NIH HHS U54 HG007010NIAID NIH HHS AI120766NIAID NIH HHS R01 AI120766NIAID NIH HHS U01 R01 AI 117839NICHD NIH HHS R37 HD045022NIDA NIH HHS U01 DA 040588NIDDK NIH HHS U54 DK107980NIGMS NIH HHS R01 GM 112720NIGMS NIH HHS T32 GM007287NIGMS NIH HHS T32 GM087237NIMH NIH HHS MH104610NIMH NIH HHS R01 MH104610NINDS NIH HHS NS088538NINDS NIH HHS R01 NS088538
6 · The paper itself

Abstract

Oncogenes are activated through well-known chromosomal alterations such as gene fusion, translocation, and focal amplification. In light of recent evidence that the control of key genes depends on chromosome structures called insulated neighborhoods, we investigated whether proto-oncogenes occur within these structures and whether oncogene activation can occur via disruption of insulated neighborhood boundaries in cancer cells. We mapped insulated neighborhoods in T cell acute lymphoblastic leukemia (T-ALL) and found that tumor cell genomes contain recurrent microdeletions that eliminate the boundary sites of insulated neighborhoods containing prominent T-ALL proto-oncogenes. Perturbation of such boundaries in nonmalignant cells was sufficient to activate proto-oncogenes. Mutations affecting chromosome neighborhood boundaries were found in many types of cancer. Thus, oncogene activation can occur via genetic alterations that disrupt insulated neighborhoods in malignant cells.

Indexed as

Chromosome AberrationsGene Expression Regulation, LeukemicSequence DeletionTranslocation, GeneticChromosome MappingHEK293 CellsHumansMutationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaProto-OncogenesTranscriptional Activation

Identifiers

PMID26940867
PMCPMC4884612
OpenAlexW2303393194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.